Desmopressin vs placebo
Desmopressin showed no clear difference in minor adverse events compared with placebo (low certainty).
- RR 0.86 [0.49, 1.49]1 study · 115 participantsLow
Desmopressin showed no clear difference in minor adverse events compared with placebo (low certainty).
It is very uncertain whether desmopressin changes minor adverse events compared with alpha‐blocker (very low certainty).
It is very uncertain whether desmopressin plus alpha‐blocker changes minor adverse events compared with alpha‐blocker (very low certainty).
Desmopressin plus alpha‐blocker may leads to lower minor adverse events compared with alpha‐blocker plus anticholinergic (low certainty).
The review found no eligible studies for this question.
It is very uncertain whether continuous positive airway pressure (CPAP) changes minor adverse events compared with phosphodiesterase type 5 inhibitors (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The intervention showed no clear difference in minor adverse events (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Antimicrobial showed no clear difference in minor adverse events compared with placebo or no antibiotics (low certainty).
Vitamin A leads to higher adverse events: minor gastrointestinal symptoms compared with placebo (high certainty).